Almac Group expanding its operations in Dundalk following successful inspections
Northern Ireland pharma company Almac Group is planning on expanding its operation in Dundalk after the company passed its Health Products Regulatory Authority inspections.
Almac Group, a global contract pharmaceutical development and manufacturing organisation, moved to Dundalk in January 2017 in the wake of Brexit in order to maintain and expand their foothold in the European market. Almac have also promised 100 new jobs for their Dundalk campus over the course of two years.
The approval of the HPRA means that the European Campus in Dundalk is officially licensed to conduct QP batch certification and release for both clinical trial material and commercial drug product in their Dundalk premises, located in the IDA Business Park.
Almac Group have also announced further investment in its Dundalk campus, revealing that a new QC laboratory and packaging facility for commercial drug products will be built. A dedicated 79,000ft² EU Distribution Centre for clinical trial supply is also going to be part of the investment. This will more than treble Almac Group’s GMP footprint in Dundalk. The new facilities are scheduled to be operational by January 2019.
Almac Group’s CEO and Chairman, Alan Armstrong, says that passing the HPRA inspections is a “key milestone.” He also added that the further expansion of the Dundalk campus will make sure that their clients will still have access to the EU marketplace. “Crucially, this will ensure an uninterrupted service provision through any uncertainty Brexit may bring, and for the future, keeping Almac as a global leader in the life sciences sector,” Mr Armstrong concludes.
The CEO of IDA Ireland, Martin Shanahan, pointed out how strategically important Dundalk is for Almac’s global footprint. “This further investment in Almac’s European Campus in Dundalk is a very positive development for the company and the North-East region… companies continue to choose Ireland as a location which provides certainty of access to the European Union in the long-term post Brexit.”
Minister for Business, Enterprise and Innovation Heather Humphreys TD also welcomed this good news for Dundalk. “This decision by Almac is a great vote of confidence in Dundalk, especially coming so soon after their initial decision to develop an operation in the area,” she says. She also believes that Almac’s expansion in Dundalk further strengthens the North East’s Life Sciences capabilities and builds on other new IDA projects announced in Dundalk and Co. Louth. “This exciting new facility is a further example of the success of our commitment under the Regional Action Plans for Jobs to provide quality jobs in regional locations,” she says.